angiotensin ii has been researched along with Status Epilepticus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bu, N; Li, Y; Ma, X; Sun, H; Wang, H; Wu, H; Yu, X; Zhan, S; Zhang, G; Zhang, R | 1 |
| Atanasova, D; Ivanova, NM; Lazarov, N; Mitreva, R; Pechlivanova, DM; Stoynev, AG; Tchekalarova, JD | 1 |
2 other study(ies) available for angiotensin ii and Status Epilepticus
| Article | Year |
|---|---|
Angiotensin II and its receptor in activated microglia enhanced neuronal loss and cognitive impairment following pilocarpine-induced status epilepticus.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cognition Disorders; Hippocampus; Losartan; Male; Microglia; Neurons; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Status Epilepticus | 2015 |
Long-term intracerebroventricular infusion of angiotensin II after kainate-induced status epilepticus: Effects on epileptogenesis, brain damage, and diurnal behavioral changes.
Topics: Angiotensin II; Animals; Anticonvulsants; Behavior, Animal; CA1 Region, Hippocampal; Circadian Rhythm; Disease Models, Animal; Infusions, Intraventricular; Kainic Acid; Male; Neuroprotective Agents; Rats; Rats, Wistar; Spatial Memory; Status Epilepticus | 2015 |